Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Product prescribing issue? 68 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Product prescribing issue have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.

68
Reports of Product prescribing issue with RISPERIDONE
0.1%
of all RISPERIDONE reports
4
Deaths
24
Hospitalizations

How Dangerous Is Product prescribing issue From RISPERIDONE?

Of the 68 reports, 4 (5.9%) resulted in death, 24 (35.3%) required hospitalization, and 19 (27.9%) were considered life-threatening.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 68 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which RISPERIDONE Alternatives Have Lower Product prescribing issue Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue RISPERIDONE Demographics